A Summary of the 2020 Gastric Cancer Summit at Stanford University
- PMID: 32707045
- PMCID: PMC7577947
- DOI: 10.1053/j.gastro.2020.05.100
A Summary of the 2020 Gastric Cancer Summit at Stanford University
Abstract
There exists no coherent national strategy for the early detection or prevention of gastric cancer in the United States (US), even among identified high-risk groups such as Asian Americans, African Americans, Hispanic Americans, and Alaska Native/American Indian peoples. As a result, patients with gastric cancer in the US are diagnosed at later stages and demonstrate worse overall survival compared to nations of East Asia with established screening programs (Table 1). The under-recognition of gastric cancer risk within minority communities is a significant unaddressed healthcare disparity.
Conflict of interest statement
Figures
References
-
- Huang RJ, Ende AR, Singla A, et al. Prevalence, risk factors, and surveillance patterns for gastric intestinal metaplasia among patients undergoing upper endoscopy with biopsy. Gastrointest Endosc 2020;91:70–77 e1. - PubMed
-
- Woo Y, Hyung WJ, Pak KH, et al. Robotic gastrectomy as an oncologically sound alternative to laparoscopic resections for the treatment of early-stage gastric cancers. Arch Surg 2011;146:1086–92. - PubMed
-
- Saumoy M, Schneider Y, Shen N, et al. Cost Effectiveness of Gastric Cancer Screening According to Race and Ethnicity. Gastroenterology 2018;155:648–660. - PubMed
-
- Jun JK, Choi KS, Lee HY, et al. Effectiveness of the Korean National Cancer Screening Program in Reducing Gastric Cancer Mortality. Gastroenterology 2017;152:1319–1328 e7. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
